Hongbin Sun

According to our database, Hongbin Sun authored at least 6 papers between 2019 and 2022.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of four.

2022

Discovery of a Novel Macrocyclic ATP Citrate Lyase Inhibitor.

Yongjun Zang, Luyang Tai, Yuanyang Hu, Yu Wang, Hongbin Sun, Xiaoan Wen, Haoliang Yuan, Liang Dai

J. Chem. Inf. Model., 2022

2021

Discovery of Novel Small Molecule Inhibitors Disrupting the PCSK9-LDLR Interaction.

Hengzhi Sun, Jinzheng Wang, Shengjie Liu, Xinyu Zhou, Liang Dai, Caiping Chen, Qinglong Xu, Xiaoan Wen, Keguang Cheng, Hongbin Sun, Haoliang Yuan

J. Chem. Inf. Model., 2021

2020

In Silico Screening-Based Discovery of Novel Inhibitors of Human Cyclic GMP-AMP Synthase: A Cross-Validation Study of Molecular Docking and Experimental Testing.

Wenfeng Zhao, Muya Xiong, Xiaojing Yuan, Minjun Li, Hongbin Sun, Yechun Xu

J. Chem. Inf. Model., 2020

Discovery of Ubiquitin-Specific Protease 7 (USP7) Inhibitors with Novel Scaffold Structures by Virtual Screening, Molecular Dynamics Simulation, and Biological Evaluation.

Shengjie Liu, Xinyu Zhou, Minglei Li, Wenfeng Zhao, Shuxi Zhou, Keguang Cheng, Qinglong Xu, Caiping Chen, Xiaoan Wen, Hongbin Sun, Haoliang Yuan

J. Chem. Inf. Model., 2020

Discovery of Novel Peroxisome Proliferator-Activated Receptor α (PPARα) Agonists by Virtual Screening and Biological Evaluation.

Liang Dai, Zhiqi Feng, Rili Zha, Keguang Cheng, Xiaoan Wen, Hongbin Sun, Haoliang Yuan

J. Chem. Inf. Model., 2020

2019

A Selectivity Study of FFAR4/FFAR1 Agonists by Molecular Modeling.

Xiangying Zhang, Hongbin Sun, Xiaoan Wen, Haoliang Yuan

J. Chem. Inf. Model., 2019